Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NUVB Hot Sheet
Join SI Premium – FREE
Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $41.9 million versus the consensus estimate of $38.55 million.
For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
